These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 4090451

  • 1. [Clinical study of the effect of the administration of cathergen preparation in patients with chronic hepatic lesions].
    Maleev A, Tsvetkova V, Krŭstev Z, Kostova N, Lukanov L.
    Vutr Boles; 1985; 24(5):39-43. PubMed ID: 4090451
    [No Abstract] [Full Text] [Related]

  • 2. [A new therapy of hepatic insufficiency. Experiments with (+)-3--cyanidanol. Its importance in the treatment of alcoholic hepatitis].
    Traissac FJ, Borg R.
    Minerva Dietol Gastroenterol; 1977; 23(3):237-42. PubMed ID: 372845
    [No Abstract] [Full Text] [Related]

  • 3. Effect of Catergen [(+)cyanidanol-3] on some haemostatic parameters in chronic liver diseases.
    Pfliegler G, Boda Z, Dalmi L, Weisz G, Misz M, Beck P.
    Ther Hung; 1984; 32(1):19-25. PubMed ID: 6571189
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment of chronic diseases of the liver with catergen].
    Loginov AS, Dzhalalov KD, Blok IuE, Bendikov EA, Ausheva LKh.
    Ter Arkh; 1986; 58(2):73-6. PubMed ID: 3704945
    [Abstract] [Full Text] [Related]

  • 5. [Enzymologic evaluation of the effectiveness of the hepatotropic drug catergen in chronic liver diseases].
    Tamarkina AD, Neverov IV, Turitsyna IG, Dement'eva ES, Krylova NI.
    Sov Med; 1985; (12):26-30. PubMed ID: 4095626
    [No Abstract] [Full Text] [Related]

  • 6. [Effect of carsil and legalon in treating chronic liver diseases].
    Brailski Kh, Chernev K, Etŭrska M, Donov M, Velev G.
    Vutr Boles; 1986; 25(3):43-9. PubMed ID: 3765578
    [Abstract] [Full Text] [Related]

  • 7. [Study of therapy in chronic liver diseases. Double-blind study with cianidanol].
    Machalke K, Müller B.
    Fortschr Med; 1982 Apr 15; 100(14):665-7. PubMed ID: 6123478
    [No Abstract] [Full Text] [Related]

  • 8. [Use of ornithine carbamoyltransferase in the treatment of liver diseases].
    Caruso N, De Jacobis M, Roccato M, Sequino A, Sgoifo B, Tinello M.
    Clin Ter; 1984 Jul 15; 110(1):37-44. PubMed ID: 6237844
    [No Abstract] [Full Text] [Related]

  • 9. [Treatment of chronic hepatitis patients with catergen].
    Karkishchenko NN, Okorokov AN, Fedorov NE, Laktionova AA, Sidorenko LF.
    Ter Arkh; 1986 Jul 15; 58(2):76-9. PubMed ID: 3704946
    [Abstract] [Full Text] [Related]

  • 10. [Clinical experience with silymarin in the treatment of chronic liver disease(author's transl)].
    Reutter FW, Haase W.
    Schweiz Rundsch Med Prax; 1975 Sep 09; 64(36):1145-51. PubMed ID: 1099576
    [No Abstract] [Full Text] [Related]

  • 11. Clinical, enzymological and histological changes in chronic diffuse liver diseases following (+)-cyanidanol-3 (Catergen) treatment.
    Halmy L, Dávid K, Nagy I, Stotz G, Kelemen JT.
    Acta Physiol Hung; 1984 Sep 09; 64(3-4):461-70. PubMed ID: 6152370
    [Abstract] [Full Text] [Related]

  • 12. [Clinical investigation of silymarin in chronic liver diseases (author's transl)].
    Realini S, Gonvers JJ, Hofstetter JR.
    Schweiz Rundsch Med Prax; 1975 May 13; 64(19):595-8. PubMed ID: 51497
    [No Abstract] [Full Text] [Related]

  • 13. [Thiomesterone and liver function].
    Pickert H.
    Med Klin; 1968 Aug 02; 63(31):1222-6. PubMed ID: 5719699
    [No Abstract] [Full Text] [Related]

  • 14. [The anti-steatosic effect of sulfo-adenosylmethionine (SAMe) in various forms of chronic hepatopathy. Multicentric research].
    Mazzanti R, Arcangeli A, Salvadori G, Smorlesi C, Di Perri T, Auteri A, Boggiano CA, Pippi L, Toti M, Boncompagni P, Angioli D, Caremani M, Magnolfi F, Camarri E, Motta R, Forconi A, Candidi Tommasi A, Lomi M, Soldi A.
    Minerva Med; 1978 Oct 13; 69(48):3283-92. PubMed ID: 724140
    [No Abstract] [Full Text] [Related]

  • 15. Therapeutic effect of (+)-cyanidanol-3 in toxic alcoholic liver disease and in chronic active hepatitis.
    Abonyi M, Kisfaludy S, Szalay F.
    Acta Physiol Hung; 1984 Oct 13; 64(3-4):455-60. PubMed ID: 6397971
    [Abstract] [Full Text] [Related]

  • 16. [Hepatoprotective drugs. Clinical results of the use of a sulfhydryl-methylating preparation].
    Rapino P, Marulli R, Rapex G, Della Lunga S, Sabatino P.
    Minerva Med; 1982 Oct 20; 73(40):2853-60. PubMed ID: 7133498
    [No Abstract] [Full Text] [Related]

  • 17. [Glucocorticoids in chronic liver diseases].
    Maier KP, Talke H, Gerok W.
    Dtsch Med Wochenschr; 1975 Mar 14; 100(11):560-3. PubMed ID: 1116441
    [No Abstract] [Full Text] [Related]

  • 18. [Clinical experimentation with Aïcamine in hepatic insufficiency].
    Négret JP.
    Bord Med; 1972 Apr 14; 5(8):973-6. PubMed ID: 5053280
    [No Abstract] [Full Text] [Related]

  • 19. Effects of (+)-cyanidanol-3 on chronic liver injury.
    Kovách G, Salamon F.
    Acta Physiol Hung; 1984 Apr 14; 64(3-4):443-8. PubMed ID: 6152368
    [Abstract] [Full Text] [Related]

  • 20. [What is certain in the therapy of hepatocellular diseases with cyanidanol?].
    Schomerus H.
    Internist (Berl); 1983 Dec 14; 24(12):684-9. PubMed ID: 6363332
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.